The Marcelle Ruth Cancer Centre & Specialist Hospital in Lagos has formalized a strategic partnership with The Royal Marsden NHS Foundation Trust in London, aiming to enhance cancer care delivery across West Africa. The collaboration focuses on clinical expertise, research, and professional development, facilitating knowledge exchange and expanding training opportunities for healthcare professionals in Nigeria and the region. Modupe Elebute-Odunsi, founder and CEO of Marcelle Ruth Cancer Centre, highlighted the significance of the agreement, citing her personal history with The Royal Marsden, where she trained as an oncology specialist in the 1990s. "This partnership is a full-circle moment for me," she said, emphasizing its role in realizing her vision of providing world-class oncology care without requiring Nigerians to seek treatment abroad.",
Elebute-Odunsi’s professional journey includes training at London institutions such as St Bartholomew’s Hospital, St George’s Hospital, and The Royal Marsden, alongside earning a Doctor of Medicine degree from the University of London. The Royal Marsden, established in 1851, is a leading cancer care institution with facilities in Chelsea and Sutton, a medical daycare unit in Kingston, Surrey, and research collaborations with the Institute of Cancer Research. The partnership, according to Elebute-Odunsi, transcends corporate ties, positioning itself as a platform for shared knowledge, advanced research, and clinical excellence to benefit patients across Nigeria and West Africa. "This is a promise of international standards, cutting-edge science, and compassionate care right here in Lagos," she stated.
The Marcelle Ruth Cancer Centre, launched in December 2020, operates a Victoria Island facility equipped with 18 inpatient beds, two modular theatres, a chemotherapy and day care suite, and a TruBeam linear accelerator. Its diagnostic services include a 64-slice CT simulator, 3D mammography, and an on-site multidisciplinary laboratory. The collaboration with The Royal Marsden is expected to strengthen Nigeria’s healthcare infrastructure, addressing the growing demand for specialized cancer treatment and reducing reliance on foreign medical facilities. The partnership underscores a broader effort to localize advanced oncology care, aligning with global health equity goals and improving outcomes for patients in a region with limited access to high-level cancer services.
The Royal Marsden’s involvement also highlights the potential for cross-border academic and clinical collaboration, leveraging its expertise in cancer research and treatment to support capacity-building in Nigeria. Elebute-Odunsi’s leadership, informed by her extensive training in the UK, positions the Lagos centre as a regional hub for innovation in oncology. As the partnership progresses, its impact on patient care, medical training, and research in West Africa will be closely monitored, reflecting a critical step toward sustainable healthcare development in the region.